Advanced Therapeutics
What Is THERAKOS Photopheresis?
The THERAKOS® Photopheresis System is an immunomodulatory therapy that uses extracorporeal photopheresis (ECP) to help enhance immunologic response. THERAKOS Photopheresis was first approved by the FDA in 1987 for the palliative treatment of CTCL skin symptoms in patients who were not responsive to other types of treatment.
About Infomed
Infomed is a Swiss company based in Geneva dedicated to the development and manufacturing of blood purification devices since 1997. We design, produce and distribute blood purification devices for application in nephrology, intensive care, hematology and cardiology.
Infomed has been focusing on all aspects of blood and plasma purification for more than 20 years, including dialysis, filtration, adsorption as well as combinations of these. For example, with Double Filtration which is a 2-step process. We are at the forefront of innovation with a large number of patents, and we use our expertise to serve others.